Joe Biden’s Prostate Cancer Has Spread Further, Hunter Biden Says 
Trump Administration Plans $1 Billion Security Aid Package for Colombia 
U.S. Unseals Charges Against Five Alleged CJNG Leaders, Raises Reward for New Cartel Chief 
Russian Strikes Kill Six in Eastern and Northern Ukraine, Dozens Injured 
Germany Warns of Daily Hybrid Warfare Threats 
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
US Expands Social Media Vetting to Foreign Journalists Seeking Visas 
New Zealand MMP Electoral System Faces Fresh Referendum Debate 
Ukraine Agrees to Protect Kazakhstan Oil Exports via Black Sea 
Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act 
ICE to Complete Nationwide Body Camera Rollout by End of August 
Taiwan President Lai Oversees Coastal Strike Drills in Han Kuang War Games 
Rubio, UK’s Miliband Stress Stronger European Security Role in Washington Talks 
Trump Faces Tough Choices as Iran War Drags On 
Trump Unveils $3 Billion U.S. Critical Minerals Push 
Russian Strikes on Ukraine Kill Six, Wound Dozens in Balakliia and Sumy 
Russia Intensifies Drone and Bomb Attacks on Ukraine’s Zaporizhzhia, Deepening Civilian Fear 
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
